
Vigil Neuroscience, Inc.
NASDAQ:VIGL
2.42 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|---|
Assets: | |||||
Current Assets: | |||||
Cash & Cash Equivalents
| 39.019 | 51.992 | 186.605 | 91.42 | 24.151 |
Short Term Investments
| 58.776 | 65.948 | 0 | 0 | 0 |
Cash and Short Term Investments
| 97.795 | 117.94 | 186.605 | 91.42 | 24.151 |
Net Receivables
| 0 | 1.485 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 10.557 | 0 | 0 |
Other Current Assets
| 2.19 | 2.482 | 11.2 | 6.063 | 1.145 |
Total Current Assets
| 100.584 | 121.907 | 197.805 | 97.483 | 25.296 |
Non-Current Assets: | |||||
Property, Plant & Equipment, Net
| 16.087 | 17.941 | 1.395 | 1.274 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0.927 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 1.02 | 1.01 | 0.266 | 3.684 | 0 |
Total Non-Current Assets
| 17.107 | 18.951 | 2.588 | 4.958 | 0 |
Total Assets
| 117.691 | 140.858 | 200.393 | 102.441 | 25.296 |
Liabilities & Equity: | |||||
Current Liabilities: | |||||
Account Payables
| 1.967 | 1.946 | 1.942 | 3.977 | 1.107 |
Short Term Debt
| 1.036 | 0.905 | 0.352 | 1.746 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 4.915 | 0 |
Other Current Liabilities
| 31.144 | 8.81 | 9.018 | 4.158 | 0.888 |
Total Current Liabilities
| 34.147 | 11.661 | 11.312 | 9.881 | 1.995 |
Non-Current Liabilities: | |||||
Long Term Debt
| 0 | 12.945 | 0 | 0.064 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 161.939 | 51.584 |
Total Non-Current Liabilities
| 11.909 | 12.945 | 2.118 | 162.003 | 51.584 |
Total Liabilities
| 46.056 | 24.606 | 11.312 | 171.884 | 53.579 |
Equity: | |||||
Preferred Stock
| 0 | 0 | 200.393 | 72.327 | 47.034 |
Common Stock
| 0.004 | 0.004 | 0.004 | 0 | 0 |
Retained Earnings
| -307.028 | -222.772 | -140.134 | -71.829 | -28.546 |
Accumulated Other Comprehensive Income/Loss
| 0.027 | -0.005 | -0 | 0 | -0 |
Other Total Stockholders Equity
| 378.632 | 339.025 | 329.211 | 91.998 | -46.771 |
Total Shareholders Equity
| 71.635 | 116.252 | 189.081 | -69.443 | -28.283 |
Total Equity
| 71.635 | 116.252 | 189.081 | -69.443 | -28.283 |
Total Liabilities & Shareholders Equity
| 117.691 | 140.858 | 200.393 | 102.441 | 25.296 |